Replies to post #359432 on NorthWest Biotherapeutics Inc (NWBO)

[marzan]

This Five Prime is still in Phase 3 and its therapy has a potential to work on only 30% of the gastric cancer patients. Just one indication 30% that too if successful. AMGN paid ~$2B. The shorts know we got the winner. They will have to cover. They shouldn't underestimate LP.

[JTORENCE]

jimmy667 Their float is only 37 million that's why the price is high. We have 1 billion shares so you cannot compare their price with ours..imo